Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.

Burning, blisters, pain: More than 40 million people worldwide are infected with the herpes virus every year. The virus can pose a serious threat to newborns and people with weakened immune systems.

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, ...

Contraception goes beyond pregnancy prevention—it’s key to protecting sexual health. Barrier methods like condoms and dental ...

Getting a herpes diagnosis can feel like a death knell for your sex life. But, as these women can attest to, that’s not the case at all ...

Burning, blisters, pain: More than 40 million people worldwide are infected with the herpes virus every year. The virus can pose a serious threat to newborns and people with weakened immune systems.

Cold sores are more prevalent than most people know, but with a combination of anxiety, stigma, and confusion. Most are ...

HSV-2 and VZV, and is expected to have activity against CMV, HHV-6, and HHV-8 as well. The Company has also developed an anti-HIV drug candidate, NV-HIV-1, that has shown strong efficacy in ...

Company will provide an overview of the pritelivir clinical development program in two oral presentations including a comprehensive Phase 2 data ...

A recent analyst initiation has brought Assembly Biosciences into focus for investors. JMP Securities commenced coverage of the biopharmaceutical firm with a "Market Outperform" rating, highlighting ...